title: Dabigatran monitoring made simple?
authors.affiliation: Dr. Jeffrey Weitz, Thrombosis Atherosclerosis Research Institute, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada, Tel.: +1 905 574 8550, Fax: +1 905 575 2646, E-mail: weitzj@taari.ca.
authors.forename: J W
authors.initials: JW
authors.lastname: Eikelboom
authors.forename: J I
authors.initials: JI
authors.lastname: Weitz
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000737:chemistry; D000991:Antithrombins / Q000008:administration & dosage* / Q000097:blood; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D002138:Calibration; D000069604:Dabigatran; D016903:Drug Monitoring / Q000379:methods*; D006470:Hemorrhage; D006801:Humans; D010314:Partial Thromboplastin Time / Q000379:methods*; D012016:Reference Values; D012044:Regression Analysis; D012107:Research Design; D012306:Risk; D013917:Thrombin / Q000037:antagonists & inhibitors; D013997:Time Factors; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D013917:Thrombin; D000069604:Dabigatran